Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?

P. Samara, Kyriaki Ioannou, O. E. Tsitsilonis*

*Corresponding author for this work

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    25 Citations (Scopus)

    Abstract

    The thymus gland produces soluble molecules, which mediate significant immune functions. The first biologically active thymic extract was thymosin fraction V, the fractionation of which led to the isolation of a series of immunoactive polypeptides, including prothymosin alpha (proTα). ProTα displays a dual role, intracellularly as a survival and proliferation mediator and extracellularly as a biological response modifier. Accordingly, inside the cell, proTα is implicated in crucial intracellular circuits and may serve as a surrogate tumor biomarker, but when found outside the cell, it could be used as a therapeutic agent for treating immune system deficiencies. In fact, proTα possesses pleiotropic adjuvant activity and a series of immunomodulatory effects (eg, anticancer, antiviral, neuroprotective, cardioprotective). Moreover, several reports suggest that the variable activity of proTα might be exerted through different parts of the molecule. We first reported that the main immunoactive region of proTα is the carboxy-terminal decapeptide proTα(100–109). In conjunction with data from others, we also revealed that proTα and proTα(100–109) signal through Toll-like receptor 4. Although their precise molecular mechanism of action is yet not fully elucidated, proTα and proTα(100–109) are viewed as candidate adjuvants for cancer immunotherapy. Here, we present a historical overview on the discovery and isolation of thymosins with emphasis on proTα and data on some immune-related new activities of the polypeptide and smaller immunostimulatory peptides thereof. Finally, we propose a compiled scenario on proTα’s mode of action, which could eventually contribute to its clinical application.

    Original languageEnglish
    Title of host publicationThymosins, 2016
    PublisherAcademic Press Inc l
    Pages179-207
    Number of pages29
    Volume102
    ISBN (Print)9780128048184
    DOIs
    Publication statusPublished - 2016

    Publication series

    NameVitamins and Hormones
    Volume102
    ISSN (Print)00836729

    Keywords

    • Adjuvant
    • Alarmin
    • Cancer
    • DAMP
    • Immune response
    • Immunoenhancing peptide
    • Prothymosin α
    • ProTα(100–109)
    • Thymic peptides

    Cite this